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Edited by Masayuki MiyasakaAbstract The physiological signiﬁcance of the squamous cell
carcinoma antigens 1 (SCCA1) and SCCA2, members of the
ovalbumin serpin family, remains unresolved. In this study, we
examined whether SCCA1 or SCCA2 inhibits protozoa- or
helminth-derived cysteine proteases. SCCA1, but not SCCA2,
potently inhibited the cysteine protease activities of CPB2.8
from Leishmania mexicana, cruzain from Trypanosoma cruzi,
rhodesain from Trypanosoma brucei rhodesience, and cathepsin
L2 from Fasciola hepatica. The inhibitory activities of SCCA1
were due to its resistance to cleavage by the cysteine proteases.
The ﬁndings indicate that induction of cysteine protease inhibi-
tors might be a novel defense mechanism against parasite devel-
opment.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The squamous cell carcinoma antigens 1 (SCCA1) and
SCCA2 belong to the ovalbumin-serpin family [1]. Although
SCCA1 and SCCA2 are closely homologous (91% identical
at the amino acid level), these two molecules have distinct
properties: SCCA1 inhibits cysteine proteases such as cathep-
sin K, L, and S, whereas SCCA2 inhibits serine proteinases
such as cathepsin G and human mast cell chymase [1]. The dis-
tinct speciﬁcities of SCCA1 and SCCA2 are due to the diﬀer-
ences in their reactive site loop (RSL) sequences, with only 7
amino acid residues among 13 in the RSL (amino acid 347–
359) shared between them. We have previously shown thatAbbreviations: IL, interleukin; SCCA, squamous cell carcinoma
antigen; RSL, reactive site loop; Fasciola hepatica cathepsin L, FheCL;
Endo F, N-glycosidase F; MALDI-TOF, matrix-associated laser
desorption ionization time-of-ﬂight; Ab, antibody; GAPDH, glycer-
aldehyde 3-phosphate dehydrogenase
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doi:10.1016/j.febslet.2007.07.072both SCCA1 and SCCA2 are induced by two related Th2-type
cytokines, interleukin (IL)-4 and IL-13, in bronchial epithelial
cells and keratinocytes [2,3], and that SCCA2, but not SCCA1,
inhibited the cysteine protease activities of a major mite aller-
gen, Der p 1 [4], indicating that SCCA proteins act as a defense
mechanism against extrinsic proteases. However, the physio-
logical signiﬁcance of SCCA molecules remains unresolved.
Many protozoan and helminth parasites generate abundant
Clan CA, Family C1 cysteine proteases, which are orthologues
of mammalian cathepsin L [5]. Cysteine proteases in parasitic
protozoa and helminths play key functions in diﬀerentiation of
the parasites themselves, infection to the hosts, and immuno-
modulation of the hosts [5]. In contrast, Th2-type immune
responses, particularly IL-4 and IL-13, act as a defense
mechanism against parasites, mainly helminths [6]. While
activation of mast cells and eosinophils in Th2-type immune
response is critical for expulsion of parasites, other non-
immune mechanisms, such as mucus production, smooth
muscle hyperresponsiveness, increased intestinal permeability,
and ﬁbrosis, are also important [6]. However, thus far, it is
unknown whether protease/protease inhibitor interaction is
involved in the defense mechanism against parasites.
In this study, we explored the possibility that SCCA1 and/or
SCCA2 might inhibit the catalytic activities of parasite-derived
cysteine proteases, thereby acting as a possible defense mecha-
nism against invading parasites.2. Materials and methods
2.1. Plasmids and generation of recombinant proteins
Plasmids encoding wild type SCCA1, SCCA2, and mutant types of
SCCA were prepared as previously described [4,7,8]. Glutathione S
transferase-fused SCCA proteins and recombinant proteins of
CPB2.8 from L. mexicana, cruzain from T. cruzi, rhodesain from
T. brucei rhodesience, and cathepsin L1 (FheCL1) and FheCL2 from
F. hepatica were generated as previously described [4,7–12].
2.2. Cells and transfection
Normal human epidermal keratinocytes (neonatal skin) were cul-
tured according to the manufacturer’s procedure (Clonetics). For
stimulation, cells were cultured with 10 ng/ml of human IL-4 or
50 ng/ml of human IL-13 (Peprotech). HEK293T cells were culturedblished by Elsevier B.V. All rights reserved.
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scribed [8]. In some experiments, 82 h after IL-4/IL-13 was added, cells
were incubated with 2 lg/ml brefeldin A (Sigma) for 14 h at 37 C, and
the cell lysates were incubated with 25 U/ll of N-Glycosidase F (Endo
F, New England Biolabs) for 12 h at 37 C.
2.3. Enzyme assays
Enzyme assays of cysteine proteases were performed modifying the
previous methods [4,7,8]. The enzymes were pre-activated by incuba-
tion with 10 mM DTT for 10 min at 37 C. After incubation of either
0.5 nM (CPB2.8, cruzain or rhodesain) or 5 nM (FheCL1 or FheCL2)
of cysteine proteases with the reaction buﬀer (400 mM sodium acetate;
pH 5.0, 4 mM EDTA, 8 mM DTT, and 0.001% BSA) for 10 min at
37 C, the indicated concentration of GST-fused SCCA proteins was
added to the mixture followed by incubation for 20 min at 37 C.
Upon addition of 25 lM substrate to the reaction mixture, the residual
enzyme activity was measured.
2.4. Cleavage assay of SCCA proteins by cysteine proteases
Two micromolar of pre-activated cysteine proteases and SCCA pro-
teins were mixed in phosphate reaction buﬀer for various time periods
at 37 C or for 2 h at 4 C. Then the reactive samples were subjected to
SDS–PAGE or Voyager RP matrix-associated laser desorption ioniza-
tion time-of-ﬂight (MALDI-TOF) mass spectrometry (PerSeptive Bio-
systems).
2.5. Western blotting
Western blotting was carried out as previously described [4,7,8]. The
membranes were probed with 100-fold diluted anti-SCCA1 or anti-
GAPDH antibody (Ab, Santa Cruz Biotechnology).
2.6. Amino acid sequencing analysis
The peptides transferred to PVDF membranes (BIO-RAD) and
stained with Coomassie Brilliant Blue R250 in 50% methanol were sub-1 2 3 54 6 7 80
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Fig. 1. Inhibition of parasite-derived cysteine proteases by SCCA proteins. CP
(D; 5 nM), or FheCL2 (E; 5 nM) was incubated with SCCA1 (open circles) o
The residual enzyme activities are depicted. The same experiments were perfjected to an Applied Biosystems Procise 494 HT protein sequencer
(ABI Applied Biosystems).3. Results
3.1. Inhibition of catalytic activities of parasite-derived cysteine
proteases by SCCA 1
To examine whether SCCA proteins inhibits the catalytic
activities of parasite-derived cysteine proteases, we chose
CPB2.8 from L. mexicana, cruzain from T. cruzi, and rhodes-
ain from T. brucei rhodesience, as cysteine proteases of proto-
zoa, and FheCL1 and FheCL2 from F. hepatica, as cysteine
proteases of helminths. The whole identities between human
cathepsin L and these proteases are 28–41%, and the identities
among these parasite proteases are 25–78%. FheCL1 and
FheCL2 share the highest homology, 78% (Suppl. Fig. 1).
The catalytic triads formed by cysteine, histidine, and aspara-
gine residues are conserved in all these proteases.
SCCA1 potently inhibited the catalytic activities of CPB2.8,
cruzain, rhodesain, and FheCL2, in a dose-dependent manner,
but was less eﬀective against FheCL1, whereas SCCA2 did not
show such potency (Fig. 1A–E). The inhibitory activities of
SCCA1 against parasite-derived cysteine proteases were al-
most equal to those against human cathepsin L and papain
[7]. In contrast, neither SCCA1 nor SCCA2 inhibited Arg-
and Lys-gingipains derived from Porphyromonas gingivalis,
major virulence factors in pathogenesis of periodontitis (data
not shown, Ref. [13]), showing the existence of the speciﬁcity1 2 3 54 6 7 80
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uzain C
B2.8 (A; 0.5 nM), cruzain (B; 0.5 nM), rhodesain (C; 0.5 nM), FheCL1
r SCCA2 (closed circles) at the indicated inhibitor/enzyme (I/E) ratio.
ormed at least three times, and the mean values are shown.
4262 S. Kanaji et al. / FEBS Letters 581 (2007) 4260–4264of SCCA1 for microbe-derived cysteine proteases. These
results demonstrated that SCCA1 had broad-spectrum inhibi-
tory activity on a variety of parasite-derived cathepsin L-like
cysteine proteases.
3.2. Resistance of SCCA1 to cleavage by parasite-derived
cysteine proteases
Serpins exert their protease-inhibitory activities by the sui-
cide substrate-like mechanism, in which the RSLs of serpins
are recognized by proteases as a bait mimicking a normal sub-
strate [1]. We have previously demonstrated, however, that the
RSL of SCCA2 inhibited Der p 1 by binding to its active site
but resisting cleavage [4]. Here, we investigated whether
SCCA1 employs the same inhibitory mechanism on parasite-
derived cysteine proteases. By incubation of SCCA1 with
CPB2.8, cruzain, rhodesain and FheCL2 for 30 min, 42–75%
of SCCA1 still existed, intact, although FheCL1 quickly
degraded SCCA1 (Fig. 2A). In contrast, SCCA2 was immedi-
ately digested by all the investigated proteases except
cruzain. The resistance of SCCA1 to cleavage by parasite-
derived cysteine proteases was consistent with the inhibitory
activities of SCCA1 against these proteases (see Fig. 1). Appli-
cation of the cleaved peptides to MALDI-TOF mass spectrom-
etry showed that the cleavage sites of CPB2.8, cruzain,
rhodesain and FheCL2 within SCCA1 were the same, the bond
between Gly-351 and Phe-352 (Fig. 2B). Taken together, resis-
tance of SCCA1 to cleavage by parasite-derived cysteine pro-
teases contributed to the inhibitory activities of SCCA1 on
these proteases.
3.3. Identiﬁcation of the amino acids in SCCA1 critical for their
inhibitory activities against parasite-derived proteases
It seemed likely that the distinct inhibitory properties of
SCCA1 and SCCA2 towards parasite-derived cysteine prote-
ases are due to the diﬀerences in their RSL sequences. The
exchange of the RSL, including distal and proximal hinge
regions of SCCA1, for that of SCCA2 attenuated the inhibi-
tory eﬀects, whereas the opposite exchange acquired the inhib-
itory eﬀects, demonstrating that the inhibitory eﬀect on
parasite-derived cysteine proteases was predominantly depen-
dent on this region of SCCA1 (Table 1, SCCA1 RSL2, SCCA2
RSL1). We then generated ﬁve mutated types of SCCA1, in*
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Fig. 2. Cleavage proﬁles and sites of SCCA1 by parasite-derived cysteine pro
derived cysteine protease for the indicated times at 37 C (A) or for 2 h at 4 C
(A) or MALDI-TOF mass spectrometry (B). In A, the single and double aster
the bold and dashed arrows represent the major and minor cleavage sites ofwhich each amino acid speciﬁc for the RSL of SCCA1 was
exchanged with that corresponding to SCCA2, and analyzed
their inhibitory eﬀects on parasite-derived cysteine proteases.
Replacing Phe-352 or Gly-353 with Val or Glu, respectively,
resulted in attenuation of the inhibitory eﬀects (Table 1,
SCCA1 mut2, SCCA1 mut3), whereas the other three muta-
tions inhibited the proteases as well as SCCA1. Taken together
with the results that the bond between Gly-351 and Phe-352
was the cleavage site by parasite-derived cysteine proteases
(Fig. 2B), we concluded that Phe-352 and Gly-353 at the posi-
tions of P1 0 and P2 0 were critical for SCCA1 to exert its inhib-
itory eﬀects on parasite-derived cysteine proteases.
3.4. Secretion of SCCA proteins from epithelial cells
If SCCA1 inhibits the catalytic activities of parasite-derived
cysteine proteases in their mammalian hosts acting as a defense
mechanism against the parasites, SCCA1 could be secreted
from its producing cells and interact with the proteases extra-
cellularly. However, the amino acid sequences of SCCA1 and
SCCA2 do not show the existence of signal sequences in these
N termini, according to the SignalP 3.0 server. Therefore, we
investigated the secretory mechanism of SCCA proteins. Upon
stimulation of IL-4 or IL-13 on human keratinocytes at 48 h,
SCCA was detected inside the cells, but only slightly in the
supernatants. But after 96 h, SCCA was clearly observed in
the supernatants (Fig. 3A, data not shown). Glyceraldehyde
3-phosphate dehydrogenase (GAPDH), a representative of
cytosolic proteins, was not detected in the supernatants, sug-
gesting that the existence of SCCA proteins in the supernatants
was not due to leakage from dead cells. Treatment of brefeldin
A, a classical inhibitor of ER/Golgi-dependent protein trans-
port, on IL-4-treated keratinocytes did not attenuate secretion
of SCCA proteins (Fig. 3B). Treatment of the cell lysates of
IL-4/IL-13-stimulated keratinocytes with N-glycosidase F that
cleaves N-glycosylated sugar chains did not change the mobil-
ities of the SCCA proteins (Fig. 3C), although SCCA1/2 have
four potential N-glycosylation sites. Furthermore, the amino
acid sequencing of the secreted SCCA proteins from
HEK293T cells showed that their N termini were intact (data
not shown). Taken together, these results suggested that SCCA
proteins could be secreted from epithelial cells by an ER/
Golgi-independent pathway.2.8
esain
in
2
A1
ion
teases. SCCA1 or SCCA2 proteins were incubated with each parasite-
(B) and subjected to SDS–PAGE followed by SYPRO Ruby staining
isks represent the intact and cleaved SCCA proteins, respectively. In B,
SCCA1, respectively.
Table 1
Alignment of RSLs of SCCA proteins and their inhibitory activities
Position Proximal hinge Reactive site loop Distal hinge
340 1 2 3 4 5 6 7 8 9 350 1 2 3 4 5 6 7 8 9 364
SCCA1 G A E A A A A T A V V G F G S S P T S T H
SCCA2  V          V V E L  S P   C
SCCA1 RSL2  V          V V E L  S P   C
SCCA2 RSL1                     
SCCA1 mut1(G351V)            V         
SCCA1 mut2(F352V)             V        
SCCA1 mut3(G353E)              E       
SCCA1 mut4(S354L)               L      
SCCA1 mut5(P356S/ T357P)                 S P   
 the same amino acid as SCCA1
CPB2.8 Cruzain Rhodesain FheL1 FheL2
SCCA1 1.6 8.6 3.9 36 11
SCCA2 91.7 89 87 66 87
SCCA1 RSL2 104 96 80 nd 64
SCCA2 RSL1 61 46 60 nd 16
SCCA1 mut1(G351V) 8.5 31 5.5 nd 36
SCCA1 mut2(F352V) 33 59 36 nd 23
SCCA1 mut3(G353E) 42 78 30 nd 30
SCCA1 mut4(S354L) 1.1 19 6.9 nd 13
SCCA1 mut5(P356S/ T357P) 2.4 29 5.6 nd 14
nd; not determined.
Residual activities (%) at I/E = 2 are depicted. The representative data of two experiments are shown.
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Fig. 3. Secretion of SCCA proteins from human keratinocytes. (A,B) Human keratinocytes were stimulated with 10 ng/ml of IL-4 for the indicated
time periods (A) or for 96 h (B) in the presence of 2 lg/ml of brefeldin A. The cell lysates and the supernatants concentrated by trichloroacetic acid
(sup) were subjected to SDS–PAGE and blotted with anti-SCCA1 serum (A,B) or anti-GAPDH Ab (A). (C) The cell lysates of human keratinocytes
stimulated with 10 ng/ml of IL-4 or 50 ng/ml of IL-13 were treated with 25 U/ll of N-glycosidase F (Endo F) and subjected to SDS–PAGE, followed
by blotting with anti-SCCA1 serum.
S. Kanaji et al. / FEBS Letters 581 (2007) 4260–4264 42634. Discussion
In this study, we found that SCCA1 had broad-spectrum
inhibitory activity on parasite-derived Clan CA, family C1
cysteine proteases, and so might act as a defense mechanism
against parasites. To our knowledge, this is the ﬁrst evidence
that a parasite protease can interact with a host protease
inhibitor, thereby acting as an anti-pathogen defense mecha-
nism. The notion that SCCA1 is a component of the host de-
fense against parasitic pathogens is supported by two
observations. The ﬁrst is that SCCA1 is inducible by Th2-
type cytokines, IL-4 and IL-13, which are known to play crit-
ical roles in protecting against helminths [2,3]. The secondkey observation is that SCCA1 appears to be secreted from
keratinocytes via an ER/Golgi-independent pathway, because
SCCA proteins were secreted from keratinocytes or
HEK293T cells without cleavage of their N-terminal por-
tions, without N-glycosylation, and in a way not blocked
by brefeldin A (Fig. 3, data not shown). Since it was reported
that IL-1b and galectin-1 were exported from the cells by an
ER/Golgi-independent pathway (also known as unconven-
tional protein secretion or nonclassical protein export path-
way), the list of proteins demonstrated to be secreted by
this pathway is growing [14]. Our present study suggests that
SCCA molecules are novel secreted proteins employing an
ER/Golgi-independent pathway.
4264 S. Kanaji et al. / FEBS Letters 581 (2007) 4260–4264The ﬁnding that SCCA1 inhibits several parasite-derived
cathepsin L-like proteases in spite of their low homologies
(Suppl. Fig. 1) indicates that the elements in the proteases re-
quired for the interaction with SCCA1 might be well con-
served. It was suggested that SCCA1 inhibited FheCL2, but
not FheCL1 (Fig. 1), because of the diﬀerence in their sub-
strate speciﬁcity in that FheCL2, but not FheCL1, cleaves
the substrates having hydrophobic Pro or Val at the P2 posi-
tion, corresponding to the composition of SCCA1 (Fig. 2B)
[15].
We furthermore found that resistance to cleavage by para-
site-derived cysteine proteases contributed to the potent inhib-
itory activities of SCCA1 (Fig. 2A) and that Phe-352 and
Gly-353 at the positions of P1 0 and P2 0 were critical for these
eﬀects (Table 1 and Fig. 2B). We previously demonstrated that
SCCA2 was resistant to cleavage by Der p 1, whereas SCCA1
was quickly digested by papain [4], indicating that resistance to
cleavage by cysteine proteases is a common underlying mech-
anism of potent inhibitory activities of SCCA proteins.
In conclusion, we found that SCCA1 inhibits the catalytic
activities of parasite-derived cysteine proteases, which might
act as a defense mechanism against invading parasites.
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